Archive for the ‘NISTADS’ Category
New Delhi: Ahead of Delhi’s proposed implementation of the odd-even scheme for cars plying on the city’s roads to control the alarming levels of pollution, an institute under Council of Scientific and Industrial Research (CSIR) has proposed an alternative solution to combat vehicular pollution.
National Institute of Science, Technology and Development Studies (NISTADS) proposed a virtual attendance at work and school (VAWS) scheme under which the third day of the week, Wednesday, would be a work-from-home day with two regular work days before and after…
A mid-week work-from-home, rather than licence-plate policing, may be the solution to Delhi’s pollution crisis, suggests the policy arm of the Council for Scientific and Industrial Research, India’s largest chain of publicly-funded research labs.
The Delhi government’s plan to impose restrictions on private car usage, to check air pollution, may be harder to implement and less effective than implementing a mid-week reprieve wherein, instead of commuting to work and school, employees and students could work and study from home for a day, according to the CSIR-National Institute of Science, Technology and Development Studies (NISTADS)…
Even as the Delhi government readies to introduce the odd-even plan for cars to check pollution from January 1, the Council of Scientific and Industrial Research (CSIR) proposes an alternative plan — get students and parents to study and work from home on a designated day in the middle of the week.
The rationale of the National Institute of Science Technology And Development Studies (NISTADS), a CSIR body, is that pollution in Delhi tends to accumulate through the week and so, a mid-week halt — for instance, Wednesday — would halt the build-up and make the air more breathable…
27 February 2012
India’s vaccine policy announced in April last year met with more criticism this week as two New Delhi-based science policy analysts — Y. Madhavi and N. Raghuram — made a bold and scathing attack in an opinion paper in the Indian Academy of Sciences journal Current Science. The policy, they say, is more about “spending and coverage than about protecting children”. The scientists, who have been pressing for a “comprehensive and evidence based vaccine policy” are convinced that India’s disease incidence figures and public health statistics are “dubious and industry manufactured.”
The policy is designed to justify spending public money on privately produced vaccines in the name of protection from diseases, they contend. Madhavi, from the National Institute of Science, Technology & Development Studies (NISTADS) and Raghuram, from the GGS Indraprastha University, go on point out that unlike other national policies, the draft of the vaccine policy was not made public for discussions among stakeholders before dbeing finalised. “Why was the entire drafting exercise done in such a tearing hurry and intriguing secrecy, ” they ask…….
20 July 2011
ndia and the US are collaborating on the development of a technology platform to enable local state agencies to reorganize data, some of which is restricted, in a format accessible on the Web.
The move is aimed at improving transparency in governance by the United Progressive Alliance (UPA) government, which has been facing charges of corruption in recent times.
“This (platform) will be similar to an existing initiative by the United States government called data.gov and will be developed completely free of cost,” said Aneesh Chopra , chief technology officer, office of science and technology in the US and an adviser to President Barack Obama. “It’s part of the Obama government’s push to encourage transparent sharing of resource information.”
P. Banerjee, director of the National Institute of Science, Technology and Development Studies, a Council of Scientific and Industrial Research body, is confident of several interesting studies involving the Indian Institutes of Management and the Indian Institutes of Technology if they release data.
“There may be issues of privacy, but as long as you withhold names, I don’t see why such data should be restricted in the first place,” he said…..
22 Febrary 2011
Tie-ups between Indian drug companies and multinational pharmaceutical firms, which initially received a lot of media attention, have proven to be more beneficial for big pharma than for Indian companies, according to a recent study.
The study authors found that co-operation between multinational pharmaceutical companies and Indian manufacturers had not boosted the R & D capacity of Indian pharmaceutical businesses.
They also found that there had not been any significant transfer of technology from developed countries.
…….Study author Dinesh Abrol, of the National Institute of Science, Technology and Development Studies (NISTADS), said that buying domestic Indian companies would give multinational companies fewer challenges over proprietary technology.
He said that the buyouts would ultimately lead to decreased manufacturing capacity for Indian-made generic drugs…….
05 December 2010
MANGALORE: Mangalore University vice chancellor Prof T C Shivashankaramurthy said that Mangalore University has been selected for ‘Promotion of University Research and Scientific Excellence'(Purse) programme of Science and Engineering Research Council of the department of Science and Technology.
With the varsity being selcted for Purse, a support of Rs 9 crore will be available to the varsity for three years. The selection has been done after National Institute of Science, Technology and Development Studies (NISTADS), New Delhi carried out a study in the current year using SCOPUS database on publications output for the period 1998-2008.
Varsity is one among the 29 universities the department of Science and Technology has decided to support in the country by providing incentive grant under Purse programme.
The funds should be utilised for carrying out research activities in the science departments, purchasing equipment, networking and computation facility and so on.